9 Patents
- US123576082025Methods and Compositions Utilizing Rrx-001 Combination Therapy for Radioprotection
EPICENTRX, Inc.
0 cites - 0 cites
- US122917262025A549 Host Cells Comprising a Recombinant Oncolytic Adenovirus with Modified E1A Cancer-specific Promoter
EPICENTRX, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US119999732024Method for Producing Recombinant Oncolytic Adenovirus with Modified E1a Cancer-specific Promoter
EPICENTRX, Inc.
0 cites - 0 cites